SCHEMBL30145

SCHEMBL30145

FC(F)(F)c1cc2ccccc2[nH]1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.56
AOC3 Q16853 2/20 0.52
AHR P35869 1/20 0.50
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
HPGD P15428 3/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
MAPT P10636 2/20 0.44
MEN1 O00255 1/20 0.44
CYP2C19 P33261 1/20 0.44
CASP3 P42574 1/20 0.44
KMT2A Q03164 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
LOXL2 Q9Y4K0 1/20 0.44
FLT3 P36888 1/20 0.44
CYP2A6 P11509 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30063522 1.00 KDM4E (0.56) KDM4EAOC3AHRNPC1RAB9A
Hydrochloric Acid SCHEMBL7485650 1.00 KDM4E (0.56) KDM4EAOC3AHRNPC1RAB9A
Methyl Alcohol SCHEMBL28456866 0.94 KDM4E (0.51) KDM4EAOC3AHRNPC1RAB9A
Benzenethiol SCHEMBL28338725 0.89 KDM4E (0.47) KDM4EAOC3AHRNPC1RAB9A
Benzyl Alcohol SCHEMBL28459276 0.85 IDO1 (0.44) KDM4EAOC3AHRNPC1RAB9A
SCHEMBL27459103 0.83 KDM4E (0.46) KDM4EAOC3AHRNPC1RAB9A
SCHEMBL28864005 0.82 AHR (0.53) KDM4EAOC3AHRNPC1RAB9A
SCHEMBL4419425 0.80 AHR (0.53) KDM4EAOC3AHRNPC1RAB9A
SCHEMBL7022968 0.80 AHR (0.51) KDM4EAOC3AHRNPC1RAB9A
SCHEMBL14694209 0.80 AOC3 (0.56) KDM4EAOC3AHRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117728010-A Solid electrolyte material, preparation method and solid battery 蜂巢能源科技(无锡)有限公司 2024-03-19 CN claimed
CN-117430542-B Synthesis method of trifluoromethyl indole derivative 上海恩氟佳科技有限公司 2024-03-08 CN claimed
CN-117430542-A Synthesis method of trifluoromethyl indole derivative 上海恩氟佳科技有限公司 2024-01-23 CN claimed
CN-113563334-B 3-fluoro-beta-carboline compound and preparation method and application thereof 南京林业大学 2022-05-03 CN claimed
CN-113185445-A Green synthesis method of 2-trifluoromethyl indole 国药集团化学试剂有限公司 2021-07-30 CN claimed
CN-107619385-B Method for synthesizing 2-trifluoromethyl indole by palladium-catalyzed aryl enamine intramolecular amine 温州大学 2020-02-21 CN claimed
US-12612389-B2 Benzofuran-based N-acylhydrazone derivative and pharmaceutical composition comprising same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2026-04-28 US disclosed
CN-121652049-A Indole derivative difluoromethylation and [18F ] radiolabelling method thereof 遵义医科大学 2026-03-13 CN disclosed
CN-120158215-A Multifunctional water paint for engine and preparation method thereof 陕西虹瑞化工科技有限公司 2025-06-17 CN disclosed
US-20250171420-A1 MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME MONTE ROSA THERAPEUTICS AG (CH) 2025-05-29 US disclosed
CN-117088803-B 1-Trifluoromethyl cyclopentadiene [ b ] indole compound and preparation method and application thereof 南京林业大学 2024-11-05 CN disclosed
CN-114206857-B Benzofuranyl N-acylhydrazone derivatives and pharmaceutical compositions comprising the same 韩国生命工学研究院 2024-09-06 CN disclosed
CN-118406001-A Preparation method and application of trifluoromethyl substituted indole compound promoted by visible light 华东理工大学 2024-07-30 CN disclosed
WO-1996003120-A1 INDENE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1996-02-08 WO disclosed
EP-0675110-A1 1H-Indole-3-glyoxylamide sPLA2 inhibitors ELI LILLY AND COMPANY (US) 1995-10-04 EP disclosed
US-5204471-A α-trifluoromethyl-substituted, saturated bicyclic amines BAYER AKTIENGESELLSCHAFT (DE) 1993-04-20 US disclosed
EP-0527385-A1 Alpha-trifluoromethyl substituted, saturated bicyclic amines and process for their preparation BAYER AG (DE) 1993-02-17 EP disclosed
EP-0261035-B1 INDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE IN COMBATING PARASITES AND COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1992-03-11 EP disclosed
US-4849443-A Indoles and pesticidal use thereof ROUSSEL UCLAF (FR) 1989-07-18 US disclosed
EP-0261035-A1 Indole derivatives, process for their preparation, their use in combating parasites and compositions containing them ROUSSEL-UCLAF (FR) 1988-03-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250171420-A1 MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME PSMA1, CSNK1G1, CSNK1A1 KDM4E 394/4885AOC3 3519/4885AHR 4306/4885
US-12612389-B2 Benzofuran-based N-acylhydrazone derivative and pharmaceutical composition comprising same TUBB3, TUBA1C, ACIN1 KDM4E 2935/4885AOC3 2184/4885AHR 811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.